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Understanding the transcriptional regulation of pluripotent cells is of fundamental interest and will greatly inform
efforts aimed at directing differentiation of embryonic stem (ES) cells or reprogramming somatic cells. We first
analyzed the transcriptional profiles of mouse ES cells and primordial germ cells and identified genes upregulated in
pluripotent cells both in vitro and in vivo. These genes are enriched for roles in transcription, chromatin remodeling,
cell cycle, and DNA repair. We developed a novel computational algorithm, CompMoby, which combines analyses of
sequences both aligned and non-aligned between different genomes with a probabilistic segmentation model to
systematically predict short DNA motifs that regulate gene expression. CompMoby was used to identify conserved
overrepresented motifs in genes upregulated in pluripotent cells. We show that the motifs are preferentially active in
undifferentiated mouse ES and embryonic germ cells in a sequence-specific manner, and that they can act as enhancers
in the context of an endogenous promoter. Importantly, the activity of the motifs is conserved in human ES cells. We
further show that the transcription factor NF-Y specifically binds to one of the motifs, is differentially expressed during
ES cell differentiation, and is required for ES cell proliferation. This study provides novel insights into the
transcriptional regulatory networks of pluripotent cells. Our results suggest that this systematic approach can be
broadly applied to understanding transcriptional networks in mammalian species.
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Introduction
Pluripotent stem cells can give rise to all fetal and adult cell
lineages, including the germline. The prototypical pluripo-
tent stem cells are embryonic stem (ES) cells [1,2]. ES cells are
a remarkable model for the study of early development and
hold promise as a source for cell replacement therapies [3].
To successfully manipulate ES cells in culture, it is important
to understand the mechanisms by which ES cells maintain
their self renewal and pluripotency.
ES cells are derived from the inner cell mass of the
blastocyst, a group of cells that gives rise to all cells of the
fetus. After the blastocyst implants in the uterus and
gastrulation ensues, most cells of the embryo lose the ability
to give rise to pluripotent stem cells, except for primordial
germ cells (PGCs) [4,5]. PGCs are the germline precursors that
give rise to sperm or eggs. When cultured in vitro, PGCs give
rise to embryonic germ (EG) cells, pluripotent stem cells very
similar to ES cells [6,7].
Several regulatory pathways that control ES cell pluripo-
tency and self renewal have recently been identiﬁed (reviewed
in [8]). Factors involved include the leukemia inhibitory
factor (LIF) and BMP signaling pathways [9–12], and tran-
scription factors Nanog [13,14] and Oct4 [15,16]. Interest-
ingly, the signaling pathways do not appear to be conserved
between mouse and human ES cells [17–20], but the tran-
scriptional regulators Oct4 and Nanog are required in ES
cells of both species [21–23]. Recent studies indicate that
transcription factors other than Oct4 and Nanog are also
important for maintenance of the ES cell state [24,25]. A
major goal will be to obtain a complete description of the
transcriptional regulatory networks of ES cells.
The increasing availability of whole genome sequences and
high-throughput experimental methods, such as microarrays,
have led to the development of systematic approaches for
deciphering transcriptional regulation. Such analyses gener-
ally lead to the identiﬁcation of sets of genes whose
expression is coregulated. It has been shown that genes
within a coregulated set often share common cis-regulatory
motifs, corresponding to transcription factor binding sites, in
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number of computational algorithms have been developed to
identify such regulatory motifs. These algorithms include
enumeration of overrepresented substrings or regular ex-
pression patterns, local multiple sequence alignment, or
sequence segmentation to decompose the DNA sequence into
the most plausible set of motifs [28–32]. The strategy of
identifying clusters of coregulated genes by expression
proﬁling followed by a computational search for regulatory
motifs has been successfully applied to a number of questions,
mostly in lower eukaryotes such as yeast. For mammalian
species, the problem is much more challenging [33], as the
genomes are more complex and regulation often involves
combinatorial action of transcription factors [34]. Examples
of computational de novo motif discovery followed by
experimental validation in mammalian species are scarce.
One experimentally validated case recently reported using
motif discovery to identify mouse transcription factors that
regulate oxidative phosphorylation [35].
Recent algorithms targeted at higher eukaryotes use
interspecies comparisons to identify functional motifs in
orthologous promoters [36–38], because functional elements
are subject to selective pressure and tend to evolve more
slowly than nonfunctional sequences [34]. These algorithms
typically use conserved blocks of DNA sequence that can be
aligned to reduce the background noise. However, alignment-
based approaches can miss important sequence motifs as
many regulatory sequences do not fall into conserved regions
[39,40].
In this paper, we used a combination of gene expression
proﬁling with computational genomic analyses and biochem-
ical assays to systematically identify novel cis-regulatory
sequences that control gene expression in pluripotent stem
cells. To gain insight into the transcriptional regulatory
networks of pluripotent cells, we compared the gene
expression proﬁles of ES cells and PGCs to embryonic and
adult somatic cell types. We identiﬁed clusters of genes
upregulated in ES cells and PGCs, which include several
known markers of pluripotency. To identify regulatory motifs
that control gene expression within these clusters, we
developed a novel algorithm, CompMoby. This algorithm
combines the strategies of comparative genomics with DNA
sequence segmentation to identify sets of motifs in the
upstream regions of coregulated genes. Using CompMoby, we
identiﬁed motifs that are statistically overrepresented in
genes upregulated in pluripotent cells and highly conserved
across multiple mammalian species. We demonstrate that
several of the predicted motifs are novel regulatory elements
of gene expression in mouse and human ES cells. Finally, we
show that the transcription factor NF-Y binds to one of the
motifs, is differentially expressed during ES cell differ-
entiation, and is required for ES cell proliferation.
Results
Genes Upregulated in Pluripotent Cells Are Involved in
Transcription, Chromatin Remodeling, Cell Cycle, and DNA
Repair
The identiﬁcation of the gene expression proﬁles of PGCs
and neighboring somatic cells of the genital ridge/mesoneph-
ros area (SGM) is described elsewhere (Wei et al., submitted).
Brieﬂy, PGCs and SGM cells were isolated by ﬂuorescence-
activated cell sorting from 11.5-d post coitum (dpc) mouse
embryos carrying the Oct4/EGFP transgene. This construct
has been shown to drive expression of EGFP speciﬁcally in
PGCs [41]. We then identiﬁed the gene expression proﬁles of
PGCs and SGM cells using Affymetrix U74Av2 microarrays.
The raw data can be obtained from ArrayExpress. The
complete normalized expression data can be found in Dataset
S1. We compared the gene expression proﬁles of PGCs and
SGMcellstothoseofembryonicandadultstemcells,andadult
differentiated tissues [42]. Hierarchical clustering revealed
similarities at the gene expression level between PGCs and ES
cells (Figure 1A). Furthermore, the transcription proﬁle of ES
cells is more similar to PGCs than to that of adult stem cells.
This result suggests that aspects of the transcriptional
regulation of pluripotency of ES cells are maintained in PGCs
during embryogenesis. We therefore sought to identify
clusters of genes upregulated in ES cells and PGCs, but not
in other cell types. Figure 1A depicts a composite cluster of
230 probe sets upregulated (in red) in pluripotent cells, and
downregulated or not expressed (in blue) in adult stem cells
and differentiated cells (Figure 1A and Dataset S2). These
genes are also largely downregulated upon differentiation of
ES cells, a further indication that their expression correlates
with the pluripotent state (H. Chipperﬁeld, S. Zhong, D.
Melton, and W. Wong, personal communication). This cluster
includes several known markers of pluripotency (see below).
We used Onto-Express [43] to search the Gene Ontology
database for functional categories overrepresented in the
cluster of genes upregulated in pluripotent cells (Figure 1B).
The full list of Gene Ontology categories can be found in
Datasets S3, S4, S5, and S6. Overall, our data indicate that
pluripotent cells are highly enriched for nuclear activities
related to cell cycle, DNA repair, transcription, and chroma-
tin remodeling.
Computational Identification of Putative Regulatory
Motifs
Genes coexpressed in pluripotent cells may be (at least in
part) coregulated by the same transcription factors. It follows
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Author Summary
Embryonic stem cells have two remarkable properties: they can
proliferate very rapidly, and they can give rise to all of the body’s cell
types. Understanding how gene activity is regulated in embryonic
stem cells will be an important step towards therapeutic applica-
tions. The activity of genes is regulated by proteins called
transcription factors, which bind to stretches of DNA sequences
that act as on or off switches. We identified genes that are active in
mouse embryonic stem cells but not in differentiated cells. We
reasoned that if these genes have similar patterns of activity, they
may be regulated by the same transcription factors. We therefore
developed a computational approach that takes information on
gene activity and predicts DNA sequences that may act as switches.
Using this approach, we discovered new DNA switches that regulate
gene activity in mouse and human embryonic stem cells.
Furthermore, we identified a transcription factor that binds to one
of these DNA switches and is important for the rapid proliferation of
embryonic stem cells. Our approach sheds light on the genetic
regulation of embryonic stem cells and will be broadly applicable to
questions of how gene activity is regulated in other cell types of
interest.that transcription factor binding sites responsible for driving
gene expression in pluripotent cells are likely to be over-
represented in the cis-acting regions of those genes. We
therefore took a computational approach to identify DNA
motifs that are statistically overrepresented in the putative
promoter and enhancer regions of genes upregulated in
pluripotent cells. To reduce noise in our computational
analysis, we derived a smaller subset of genes, those with highly
signiﬁcant changes in expression (standard deviation/mean .
0.6). A smaller cluster of 55 probe sets (Dataset S7) was
obtainedthatincludesseveralknownmarkersofpluripotency,
such as Oct4, Nanog, Gdf3, Dppa2, Esg1, Utf1, and Tera.
Figure 1. Identification of Genes Upregulated in Pluripotent Cells
(A) Gene expression profiling of ES cells and PGCs. Hierarchical clustering was used to identify genes upregulated in ES cells and PGCs relative to SGMs,
bone marrow (BM), hematopoietic stem cells (HSCs), lateral ventricles of the brain (LVB), and neural stem/progenitor cells (NSCs) [42]. The cluster shown
depicts gene expression of 230 probe sets upregulated in ESCs and PGCs. Red means the gene is upregulated, blue means it is downregulated.
(B) Functional annotation of genes upregulated in ES cells and PGCs. Gene Ontology analysis was performed to identify functional categories
overrepresented in the cluster of genes upregulated in pluripotent cells (A). The top pie chart represents the ontology ‘‘cellular component,’’ the
middle pie chart represents the ontology ‘‘biological process,’’ and the bottom pie chart represents the ontology ‘‘molecular function.’’ Categories
shown are significantly overrepresented at p , 0.005. Grey slices represent categories with p . 0.005.
doi:10.1371/journal.pgen.0030145.g001
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Identification of Regulatory Sequences in ES CellsTo identify cis-regulatory motifs involved in transcriptional
regulation of pluripotency-associated genes, we developed
CompMoby (Comparative MobyDick), which improves upon
MobyDick [28] by incorporating a ﬂexible analysis of evolu-
tionary conservation (Figure 2A). From a set of coregulated
genes, CompMoby builds multiple dictionaries (lists of motifs)
from the upstream noncoding sequences of individual
genomes as well as sequences conserved across species. The
motifs of these dictionaries are clustered to obtain a ﬁnal
dictionary of motif clusters. CompMoby then screens for
motif clusters that are overrepresented in the set of
coregulated genes compared to the entire genome.
Functional elements may not reside within conserved
regions [39,40], and an advantage of CompMoby is that it
does not solely rely on sequence alignments, but also uses
information from individual genomes. By combining these
two sets of information, CompMoby can identify conserved
sites that are aligned, sites that are conserved but not aligned,
and nonconserved sites. CompMoby is ﬂexible; motifs do not
have to be exactly conserved across species, since clustering
the multiple dictionaries derived from different sets of
sequences will group motifs related to each other by a few
mutations.
We employed CompMoby to identify putative cis-acting
motifs in the upstream sequences that may be shared among
upregulated genes in mouse pluripotent cells and their
human orthologs (Datasets S8–S13). From our ﬁnal dictionary
(Figure 2B and Datasets S14 and S15), we selected ten motif
clusters and used promoter alignment data between human,
mouse, rat, and dog [44] to systematically identify highly
conserved motifs and their ﬂanking regions (Figure 2C and
Dataset S16) within the promoters of genes upregulated in
pluripotent cells. We chose 25 different motifs and their
ﬂanking regions from our top ten motif clusters for further
experimental characterization (underlined sequences in
Figure 2B).
It is important to note that two of the predicted motifs
correspond to putative binding sites of known transcriptional
regulators of ES cells. The motif 7 cluster contains the
sequence ATTACAAT, which has been implicated in Sox2
binding [45]. This sequence and its ﬂanking regions are
conserved in the upstream sequences of the Nanog gene in
human, mouse, rat, and dog (Figure 2C). Interestingly, the
conserved sequence corresponds to the recently described
binding site for Oct4 and Sox2 that is required for Nanog
expression [45,46], indicating that we have indeed identiﬁed a
functional motif that regulates a pluripotency-associated
gene. Cluster 8 contains a palindromic motif that matches
the known canonical binding motif for Myc [47,48]. Although
several other members of the basic helix-loop-helix family
can bind this motif [49], it is interesting to note that c-Myc
has recently been implicated in the regulation of self-renewal
and pluripotency in mouse ES cells [50], and that it is part of a
cocktail of factors capable of inducing pluripotency [51].
These results demonstrated the power of CombMoby and
suggested that the other novel identiﬁed motifs may also be
functional.
Identification of Novel Regulatory Motifs in Mouse ES Cells
We next sought to assess the transcriptional regulatory
activity of the predicted motifs. We transfected mouse ES
cells with Fireﬂy luciferase reporter constructs containing the
motifs upstream of a heterologous thymidine kinase (TK)
minimal promoter (Figure 3). Each construct contained a
motif and its ﬂanking sequences (median length 30 bp)
present in at least two repeats (table in Figure 3A; Dataset
S18). As a positive control, we used a 242-bp fragment of the
Oct4 distal enhancer (DE) (Oct4, Figure 3A). Since one of our
predicted motifs together with its ﬂanking sequence has
already been shown to regulate Nanog and be sufﬁcient for
gene expression in ES cells [45,46], we used it as an additional
positive control (Nng, Figure 3A). Both controls contain an
Oct4/Sox2 binding site, the only known enhancer element
shown to speciﬁcally regulate expression of several genes
preferentially expressed in ES cells [45,52–56].
When compared to the construct containing only the TK
promoter (Figure 3A), 14 out of 25 motif-containing
constructs showed a change in luciferase expression in
transfected ES cells (Figure 3B, red bars), suggesting that
the predicted motifs are functional enhancers of tran-
scription. Notably, the enhancer activity of several motifs
was higher than the activity of the previously identiﬁed Oct4/
Sox2 enhancer (Figure 3B, compare motifs 1a, 1b, 2a, and 2c
to Nng).
For some motifs, we tested different numbers of repeats
(Figure 3A and Figure S1) and found that the increase in
luciferase expression was directly proportional to the number
of repeats, further suggesting that the predicted motifs act as
transcriptional activators. To determine if the observed
transcriptional activation is speciﬁc for pluripotent ES cells,
we transfected several differentiated cell types: HEK293,
NIH-3T3, and ES cells differentiated either by formation of
embryoid bodies (EBs) or addition of retinoic acid (RA)
(Figure 3B, blue bars). Several motifs showed decreased
activity in differentiated cells compared to ES cells, indicating
that they are preferentially active as transcriptional en-
hancers in pluripotent ES cells.
Two of the tested motifs appear to have repressing
activities. While showing little activity in ES cells, motif 4b
seems to downregulate expression in NIH 3T3s (which are
transformed mouse embryonic ﬁbroblasts) and EB cells
Figure 2. Computational Analysis and Identification of Regulatory Motifs
(A) Schematic diagram of the CompMoby algorithm.
(B) Top ten predicted motif clusters from CompMoby analysis of 2,000-bp sequences upstream from the transcriptional start site of 55 probe sets
upregulated in pluripotent cells. Upstream sequence sets are given as Mouse (M), Human (H), and Conserved blocks between mouse and human (C).
The fourth column lists log10 p-values, which are calculated based on overrepresentation of the motif cluster in sequences upstream of the 55 probe
sets relative to all other probe sets. p-Values are Bonferroni corrected for multiple testing. Underlined motifs were chosen for experimental
characterization.
(C) Examples of motifs (red) found by CompMoby to be highly conserved across four mammalian species. Asterisks denote bases conserved across all
four species.
doi:10.1371/journal.pgen.0030145.g002
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Identification of Regulatory Sequences in ES CellsFigure 3. Experimental Validation of Predicted Regulatory Motifs
(A) Schematic representation of constructs used in this study. A fragment of the Oct4 distal enhancer (DE, bp  2,181 to  1,939) (Oct4), and the Oct4/
Sox2 regulatory motif identified in cluster 7 and comprising a part of the Nanog promoter (bp  190 to  156) (Nng) were used as positive controls.
Predicted motif sequences (1a, 1b, ..., 10b) were fused to a construct containing Firefly luciferase driven by a minimal TK promoter. The number of
repeats for a given motif is indicated in the right panel. Constructs 2c and 8a bear two repeats of genomic sequence that each contains two predicted
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Identification of Regulatory Sequences in ES Cells(Figure 3B). Therefore, motif 4b might bind a repressor
necessary for downregulation of genes expressed in ES cells
upon differentiation. In contrast, motif 7a appears to confer
repression preferentially in ES cells, suggesting that it may
control the levels of ES cell-expressed genes (Figure 3B). In
summary, we have identiﬁed several novel cis-acting motifs
that are sufﬁcient to regulate gene expression preferentially
in undifferentiated mouse ES cells. These results demonstrate
that CompMoby can successfully predict functional motifs in
mammals and even compares favorably to studies in
organisms with simpler genomes such as yeast [57].
We decided to focus on eight motifs that showed the most
interesting levels of activity in undifferentiated versus
differentiated cells (Figure 4A). To conﬁrm that the predicted
motifs are indeed responsible for this activity, we performed
mutational analyses by introducing point mutations at every
second position of a motif sequence, with the exception of
motif 1a and 8a. Motifs 1a and 8a, while clearly belonging to
distinct motif clusters, have the sequence CACGTG in
common (Figures 2B and 4A). CACGTG has been previously
identiﬁed as a binding site for c-Myc and several other
transcription factors of the basic helix-loop-helix family (see
above), and a point mutation in CACGTG inhibits binding of
Myc proteins [58]. Therefore, we decided to introduce a
single point mutation in motifs 1a and 8a (1aM1, and 8aM,
respectively). When transfected into mouse ES cells (Figure
4B), both mutated motifs 1a and 8a showed a drastic
reduction in activity. This result indicates that their enhancer
activity is regulated by the CACGTG sequence, likely through
the binding of a basic helix-loop-helix transcription factor.
The construct tested for motif 1a contains GC-rich sequences
in the regions ﬂanking the predicted motif. Particular GC-
rich sequences may be bound by the Sp1 transcription factor
[59]. To test the contribution of ﬂanking sequences to the
activity of motif 1a, we introduced four point mutations in
each of the ﬂanking regions (1aM3), four point mutations in
the motif 1a sequence (1aM2), and both combined (1aM4).
Our results indicate that the enhancing activity of motif 1a is
due to the predicted motif sequence, and not to the ﬂanking
regions (Figure 4B). Similarly, the activity of all other motifs
was signiﬁcantly reduced or abolished when mutated,
indicating that the predicted motif sequences are responsible
for their activity.
To determine whether the identiﬁed motifs are speciﬁcally
active in ES cells only, we tested their activity in another
pluripotent cell type, EG cells. We found that all of the tested
motifs have comparable levels of activity in both pluripotent
cell types (Figure 4C). Next, we investigated whether any of
the motifs are required for regulation of gene expression in
the context of an endogenous promoter. One of the genes we
identiﬁed as upregulated in pluripotent cells is Eed (Datasets
S2 and S7), a component of chromatin remodeling complexes
that regulate transcriptional silencing in ES cells [60]. The
regulatory sequences of the Eed gene have not been described,
and the genomic sequence upstream of Eed contains several
of our predicted motifs. Point mutations in the sequences
representing predicted motifs 2 and 6 signiﬁcantly reduced
the activity of the Eed promoter (Figure 4D), indicating that
motifs 2 and 6 are necessary for maximal expression driven
by the endogenous Eed promoter. Future studies will be
necessary for complete dissection of the Eed promoter.
Nevertheless, our proof-of principle experiments demon-
strate that at least some of the motifs identiﬁed as sufﬁcient
to enhance transcription of a heterologous promoter in
pluripotent stem cells are also functional enhancers of an
endogenous promoter. In summary, we have identiﬁed novel,
bona ﬁde regulatory motifs present in genes preferentially
expressed in pluripotent cells. We anticipate that our
approach will greatly accelerate the dissection of enhancer/
promoter elements of pluripotency-associated genes.
The Identified Regulatory Motifs Are Active in Human ES
Cells
Comparative DNA sequence analysis of pluripotency-
associated genes revealed a high degree of conservation
between mouse and human for several of the identiﬁed motifs
(Figure 2C). To address whether the motifs active in mouse ES
cells are also sufﬁcient to activate transcription in human ES
cells, we compared the expression levels of constructs bearing
the identiﬁed motifs (Figure 5, red bars) with their mutated
counterparts (blue bars). Interestingly, all of the motifs
showed signiﬁcant regulatory activity in human ES cells with
levels similar to those in mouse ES cells. Likewise, the activity
was diminished or abolished upon point mutations. These
results underscore the power of our approach to predict and
identify regulatory elements and suggest a strong degree of
conservation in the transcriptional regulatory networks in
mouse and human ES cells.
Proteins Present in ES cells, Including the Transcription
Factor NF-Y, Bind Sequence-Specifically to the Motifs
For several of the motifs, we performed electrophoretic
mobility shift assays (EMSA) with biotin-labeled motif
sequences. In the presence of ES cell nuclear protein extracts,
shifted bands were observed for motifs 1a, 1b, 2a and 8a
(Figure 6A). Several of these bands represent speciﬁc protein-
motif complexes, as they were efﬁciently competed in the
presence of excess unlabeled wild-type (1a, 1b, 2a and 8a,
respectively) but not mutated probe (1aM, 1bM, 2aM and
8aM, respectively) (Figure 6A). These results show that
proteins present in ES cells bind sequence-speciﬁcally to
the motifs.
To identify putative transcription factors that can bind to
the motifs, we systematically searched databases of known
transcription factors. We did not ﬁnd a match for most of the
motifs, e.g., 1 and 2. We are particularly interested in
identifying transcription factors that bind to these motifs,
as they showed very high enhancer activity speciﬁcally in
regulatory motifs. (B) Regulatory activity of predicted motifs in mouse ES cells. Constructs described in (A) were transfected in undifferentiated mouse
ES cells (red bars); or HEK293, NIH-3T3, and ES cells differentiated by formation of EBs or addition of RA (blue bars). A plasmid containing Renilla
luciferase driven by the TK promoter was cotransfected. After 24 h, cells were lysed and assayed for luciferase activities. Firefly values were corrected for
Renilla values, and the activities of the tested constructs were calculated relative to the activity of the TK construct, which was set to 1. For
undifferentiated mouse ES cells, each construct was tested in several independent experiments (five on average), and representative results are shown.
For HEK293, NIH-3T3, EB-derived, and RA-differentiated ES cells, one representative experiment is shown for each (blue bars). Bars represent averages of
triplicates performed in each single experiment. Error bars depict standard deviation.
doi:10.1371/journal.pgen.0030145.g003
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Identification of Regulatory Sequences in ES Cellsundifferentiated ES cells (Figure 3B; compare motifs 1a, 1b,
2a, and 2c to Oct4), but these transcription factors will have
to be identiﬁed with unbiased biochemical or genetic
approaches.
For motif 6 we were able to take a candidate factor
approach. Two variants of the motif 6 (motifs 6a and 6b)
contain a CCAAT box that when mutated caused a reduction
in enhancer activity (Figures 4 and 5). CCAAT boxes have
been shown to act as enhancers of transcription [61]. To
identify the motif 6 binding factor(s), we performed EMSA.
When biotin-labeled motif 6b was incubated with ES cell
nuclear protein extracts, several shifted bands were observed
(lane 2, Figure 6B). Excess unlabeled motif 6a and 6b, but not
motif 6bM where the CCAAT box was mutated (Figure 4A),
eliminated the binding of the major band, indicating that the
band represents factor(s) speciﬁcally bound to the CCAAT
box (lanes 3–5, Figure 6B). Several proteins able to bind
CCAAT boxes have been described [62]. Among these is a
heterotrimeric factor NF-Y (composed of NF-YA, NF-YB, and
NF-YC subunits), which requires a high degree of conserva-
tion of the CCAAT sequence [63,64]. To determine whether
NF-Y binds to the CCAAT box of motifs 6a and 6b, we
performed additional EMSAs in which ES cell extracts were
preincubated with anti-NF-Y antibodies (lanes 6–9, Figure
6B). The major motif 6b–protein complex was found to be
speciﬁcally supershifted by antibodies against both NF-YA
and NF-YB (lanes 6–9, Figure 6A), but not by an unrelated
antibody (lanes 10 and 11, Figure 6B). These data show that
NF-Y binds to motif 6, indicating that the NF-Y binding site is
conserved and overrepresented in cis-acting regions of genes
preferentially expressed in pluripotent cells.
To conﬁrm that NF-Y binds directly to the promoters of
genes upregulated in pluripotent cells, we performed
chromatin immunoprecipitation (ChIP) real-time PCR.
Cdc25c is a known target of NF-Y [65] and Sall4 and Zic3 are
two of the genes with the highest levels of upregulation in
pluripotent cells, present in the cluster in Figure 1A, that
contain consensus NF-Y sites. Our ChIP data show that NF-Y
binds to the CCAAT-containing regions of these genes in ES
cells, but not to a control gene (Rpl15) that is not upregulated
in ES cells (Figure 6C).
NF-Y Is Differentially Expressed during ES Cell
Differentiation
Even though NF-Y is expressed in several cell types and
tissues [61], there is strong evidence for its differential
expression: NF-YA and NF-YC are highly upregulated in
mouse oocytes (40-fold and 12-fold, respectively, relative to
the median expression in 60 other tissues) [66]. NF-YB was
recently identiﬁed in a screen for genes upregulated in the
Figure 5. The Activity of the Identified Motifs Is Conserved in Human ES Cells
Cells were transfected and data were analyzed as described in Figure 3B. Results from one of two independent experiments are shown. Bars represent
average of duplicates performed in each single experiment, error bars depict standard deviation. Wild-type sequences, red bars; mutated sequences,
blue bars.
doi:10.1371/journal.pgen.0030145.g005
Figure 4. The Predicted Regulatory Motifs Are Sequence-Specific, Active in Both Mouse ES and EG Cells, and Act as Functional Enhancers of the
Endogenous Eed Promoter
(A) Mutations in the predicted regulatory motifs. Sequences containing the predicted regulatory motifs (depicted in red) flanked by endogenous
sequences are shown on the left. Sequences containing point mutations (depicted in blue) are shown on the right.
(B) Regulatory activity of the predicted motifs and their mutated counterparts in mouse ES cells. Data were collected and analyzed as described in
Figure 3B. Representative results from five independent experiments are shown. Bars represent averages of triplicates performed in each single
experiment. Error bars depict standard deviation. Wild-type sequences, red bars; mutated sequences, blue bars.
(C) Regulatory activity of predicted motifs and their mutated counterparts in mouse EG cells. Data were collected and analyzed as described in Figure
3B. Representative results from two independent experiments are shown. Bars represent averages of triplicates performed in each single experiment,
error bars depict standard deviation. Wild-type sequences, red bars; mutated sequences, blue bars.
(D) Activity of regulatory motifs 2 and 6 present in Eed upstream genomic sequence. A 1.7-kb fragment of Eed upstream genomic sequence (bp 1,605
toþ109 relative to the transcription start site) was cloned and fused to the Firefly luciferase reporter gene (Eed). Mouse ES cells were transfected, and
the activity of the Eed construct was compared to the activities of the construct containing luciferase reporter gene alone (ctrl), a TK-bearing construct
containing the Oct4 DE (Oct4), an Eed construct containing four point mutations in motif 2 (Eed 2M), and an Eed construct containing four point
mutations in motif 6 (Eed 6M). Data were collected and analyzed as described in Figure 3B. Results from two independent experiments are shown. Bars
represent averages of triplicates performed in each single experiment; error bars depict standard deviation. Wild-type sequences, red bars; mutated
sequences, blue bars. The same mutations also significantly reduce activity of the Eed promoter in EG cells (unpublished data).
doi:10.1371/journal.pgen.0030145.g004
PLoS Genetics | www.plosgenetics.org August 2007 | Volume 3 | Issue 8 | e145 1532
Identification of Regulatory Sequences in ES Cellsinner cell mass of the mouse blastocyst [67]. In addition,
alternative splicing produces two different NF-YA isoforms:
NF-YA(long) and NF-YA(short) [68].
We analyzed expression of NF-YA (including long and
short isoforms), NF-YB, and NF-YC during mouse and human
ES cell differentiation (Figure 7A). The levels of NF-Y mRNAs
were analyzed by real-time reverse transcriptase PCR (RT-
PCR) in mouse ES cells and differentiated ES cells either
treated with RA or induced to form EBs. Interestingly, the
expression of the two isoforms of NF-YA (long and short)
changed in opposite directions; while the levels of NF-
YA(long) increased with ES cell differentiation, NF-YA(short)
was signiﬁcantly downregulated with differentiation. At day 6
of RA-induced differentiation, NF-YA(short) was not de-
tected, and at day 7 it was detected at low levels (8-fold
reduction) (Figure 7A). The expression of NF-YB subunit was
modestly reduced (up to 2.5-fold), while that of NF-YC did
not change considerably during the course of differentiation.
Figure 6. Proteins Present in ES Cells, Including NF-Y, Bind Sequence-Specifically to the Motifs
(A) EMSA using motifs 1a, 1b, 2a and 8a. EMSA was performed with a double-stranded, biotin-labeled oligonucleotide containing the corresponding
motif in the absence or presence of ES cell nuclear extracts. Where indicated, ES cell nuclear extracts were preincubated with a 200-fold molar excess of
unlabeled competitor double-stranded oligonucleotides. For motif 8a, ES cell nuclear extracts were also preincubated with a 100-fold molar excess of
unlabeled competitor double-stranded oligonucleotides. Arrows denote specific bands.
(B) EMSA using motif 6. EMSA was performed with a double-stranded, biotin-labeled oligonucleotide containing motif 6b in the absence (lane 1) or
presence (lanes 2–11) of ES cell nuclear extracts. ES cell nuclear extracts were preincubated with a 200-fold molar excess of unlabeled competitor
double-stranded oligonucleotides (lanes 3–5), increasing amounts of a-NF-YB (lanes 6 and 7), a-NF-YA (lanes 8 and 9), or unrelated antibody (lanes 10
and 11). Arrow denotes the major specific band.
(C) ChIP-real time PCR. Chromatin was precipitated from ES cell nuclear extracts using a-NF-YB or unrelated antibody. Data represent fold enrichment in
the a-NF-YB precipitation relative to the unrelated antibody precipitation. Cdc25c is a known target of NF-Y [65] and Sall4 and Zic3 are two of the genes
with the highest levels of upregulation in pluripotent cells (Figure 1A) that contain consensus NF-Y sites. Rpl15 is a control gene that is not upregulated
in ES cells. Black and white bars represent independent experiments performed with different ES cell nuclear extracts.
doi:10.1371/journal.pgen.0030145.g006
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Identification of Regulatory Sequences in ES CellsDuring differentiation of human ES cells, the expression of
all NF-Y subunits was signiﬁcantly reduced (Figure 7A). There
is a lack of concordance of expression patterns for NF-
YA(both), NF-YA(long), and NF-YC between the mouse and
human EBs. It is possible that not all of the NF-Y subunits are
regulated in identical manner in mouse and human ES cells,
or that the cells forming in differentiated EBs, which are very
heterogeneous cell populations, differ in nature or propor-
tion in both species and have different levels of some NF-Y
subunits (particularly NF-YA[long] and NF-YC). Nevertheless,
our results show that NF-Y subunits, in particular NF-
YA(short) and NF-YB, are downregulated during differ-
entiation of mouse and human ES cells, suggesting that a
speciﬁc subunit composition of NF-Y may be critical for ES
cells.
NF-Y Regulates ES Cell Proliferation
NF-Y has been implicated in promoting proliferation
[69,70] and inhibiting differentiation [71] and senescence
[72]. NF-YA mutant mice have been reported to display early
embryonic lethality, as no mutant embryos were observed at
the earliest stage analyzed (8.5 dpc) [70]. However, the
function of NF-Y in ES cells had not been examined. We
sought to investigate the role of NF-Y in proliferation of ES
cells, using RNA interference (RNAi) in combination with a
recently described competition assay [25]. This assay meas-
ures the ability of cells undergoing RNAi and grown in the
presence of wild-type cells to maintain the rapid cell
proliferation that characterizes wild-type ES cells (Figure
7B). The results are therefore a measure of the growth rate of
ES cells undergoing RNAi relative to that of wild-type cells.
We tested the effect of lentivirus-mediated NF-Y knockdown
in mouse ES cells. As all three NF-Y subunits are required for
sequence-speciﬁc DNA binding and downregulation of any
subunit is expected to impair NF-Y binding to DNA [63,64],
we infected GFP-expressing ES cells [73] with either NF-YA or
NF-YB short hairpin RNAs (shRNAs). Similar to the control
Oct4 shRNA [25], cells infected with NF-YA or NF-YB shRNAs
were selectively out-competed by wild-type cells over time
(NF-Yai1 and NF-Ybi1, Figure 7B). To conﬁrm the RNAi
speciﬁcity and exclude possible off-target effects, we tested
NF-YA and NF-YB shRNAs that target a different region of
the mRNAs (NF-Yai2 and NF-Ybi2, respectively, Figure 7B). In
addition, an unrelated shRNA and an shRNA targeting GFP
transcript were used to exclude the possibility that the effects
observed were due to sequestration of the RNAi machinery,
rather than depletion of speciﬁc gene products (ctrl and
GFPi, respectively, Figure 7B). While the percentage of cells
infected with the unrelated or GFP shRNAs did not change
signiﬁcantly, cells infected with the NF-Yai2 and NF-Ybi2
shRNAs were out-competed by noninfected, wild-type cells.
The speciﬁcity of the NF-YA and NF-YB knockdown was
conﬁrmed by real-time RT-PCR (unpublished data). Our
preliminary results using real-time RT-PCR for several
differentiation markers do not reveal induction of differ-
entiation upon RNAi. This suggests that the primary role of
NF-Y may be to maintain the high proliferative capacity of ES
cells.
We characterized the role of NF-Y in ES cell proliferation
in more detail. Plating cells at low density revealed a strong
decrease in the clonogenic potential of ES cells undergoing
RNAi against NF-YA or B, relative to control cells (Figure 7C).
Using staining for alkaline phosphatase, a marker of
undifferentiated ES cell colonies, we did not observe partially
stained or unstained colonies upon NF-Y knockdown. The
very few colonies that formed were still alkaline phosphatase
positive, and may be due to less than 100% pure FACS
isolation of cells undergoing RNAi prior to plating, or to
incomplete knockdown of NF-Y to levels that still allow
colony formation. These data indicate that knockdown of NF-
YA or NF-YB compromises the clonogenic potential of mouse
ES cells, reducing it by 5–10-fold. Cell cycle analysis using NF-
YA knockdown ES cells revealed an increased proportion of
cells in G1 and a decreased proportion of cells in S phase
(Figure 7D). Taken together, these results indicate that
inhibition of NF-Y function leads to defects in ES cell
proliferation that correlates with an accumulation of cells at
the G1/S transition of the cell cycle.
Discussion
In this study we report a systematic approach that
combines comprehensive expression analysis of coregulated
genes, computational de novo motif prediction, biochemical
validation of cis-regulatory elements, and identiﬁcation of
transcription factors that bind to those elements in pluri-
Figure 7. NF-Y Is Differentially Expressed during ES Cell Differentiation and Is Required for ES Cell Proliferation
(A) Expression levels of NF-YA, NF-YA(long), NF-YA(short), NF-YB, and NF-YC during differentiation of ES cells. Real-time RT-PCR of RA-treated mouse ES
cells, upper left panel; EB formation by mouse ES cells, upper right panel; EB formation by human ES cells, lower left panel. Fold-changes were
calculated relative to undifferentiated ES cells using the REST software [94] and housekeeping genes as controls. A representative of at least three
experiments (each performed in duplicate) is shown. Days of differentiation are indicated next to the bars.
(B) RNAi-based competition assay. Mouse ES cells were infected with a lentiviral vector that induces RNAi and labels the cells with a red fluorescent
marker, mCherry. The percentage of cells undergoing RNAi (mCherryþ) was measured in a competition assay with noninfected wild-type cells over time.
The ratio [mCherryþ cells in RNAi against target gene/mCherryþ cells in RNAi against GFP] gives a proliferation index. In the case of cells undergoing
RNAi against GFP (GFPi), the ratio was calculated using cells infected with empty lentiviral vector as control. This index is expected to remain at 1 over
time if there are no effects of RNAi against the target gene on proliferation and to be less than 1 if there are defects in cell proliferation. We validated
our approach with RNAi against Oct4 (black bars). Downregulation of NF-YA or NF-YB leads to defective proliferation of ES cells (orange and red bars,
respectively), while the unrelated control sequence or downregulation of GFP has no effect (blue and green bars, respectively). Results from one of 3–5
independent experiments are shown. Bars represent averages of duplicates (NF-YB, control) or triplicates (NF-YA, GFP, Oct4) performed in a single
experiment.
(C) Colony-formation assay. Control (vector and GFPi) cells and cells undergoing RNAi against NF-YA or B were sorted and plated at low density (300
cells per well of a 6-well plate) in triplicates. Colonies were counted after 10 d of culture.
(D) Cell-cycle analysis. Cells infected with a lentivirus leading to NF-YA knockdown were sorted for mCherryþcells (NF-YAi), which are undergoing RNAi
against NF-YA, or mCherry- cells (mCh-), which correspond to in-plate control noninfected cells with which the NF-YA knockdown ES cells are
competing. An additional control used was ES GFPi cells. Cells were stained using propidium iodide and analyzed for DNA content using flow
cytometry. Samples were analyzed in triplicates. Error bars depict standard deviation.
doi:10.1371/journal.pgen.0030145.g007
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Identification of Regulatory Sequences in ES Cellspotent stem cells. Our methodology can be used with any set
of coregulated genes, and, as such, is broadly applicable to the
characterization of transcriptional regulatory networks. The
approach we describe compares favorably to the standard
experimental method to identify regulatory sequences, which
relies on time-consuming dissection of large noncoding
regions of a single gene. When compared to other methods
to identify cis-regulatory elements, like ChIP in combination
with microarrays (ChIP-chip) or paired-end ditag sequencing
(ChIP-PET), our approach has two principal advantages: it
does not require prior knowledge of the critical transcription
factors whose targets are to be investigated, and it is not
limited by the number of cells available for analysis. In
particular, we have been able to generate reliable expression
data from as low as 500–1,000 cells (unpublished data),
whereas current ChIP-chip and ChIP-PET methods require
several million cells [23,74,75]. Thus, we envision that the
approach described here will be particularly useful for the
characterization of transcriptional networks that regulate cell
fate decisions during embryonic development and stem cell
differentiation.
We identiﬁed short DNA sequence motifs that are highly
active in undifferentiated ES cells but not in differentiated
cells (Figure 3B, motifs 1 and 2). Importantly, the level of
activity of these motifs is signiﬁcantly higher than that of the
Oct4/Sox2 element in the Nanog promoter (Figure 3B,
compare motifs 1a, 1b, 2a, and 2c to Nng). These results
indicate that we identiﬁed enhancer elements that are bound
by transcriptional factors preferentially active in undiffer-
entiated mouse and human ES cells. The availability of
EMSAs for motifs 1 and 2 and of mutated versions that highly
reduce or abolish motif activity (Figures 4, 5, and 6A) should
facilitate the unbiased identiﬁcation of the transcription
factors that bind to these motifs.
An important validation of our systematic analysis of cis-
regulatory elements active in ES cells is the identiﬁcation of
NF-Y as a transcription factor that binds speciﬁcally to one of
those elements and regulates ES cell proliferation. In support
of our ﬁndings, the NF-Y binding site was detected as
overrepresented in genomic regions bound by Oct4 and Sox2
in human ES cells (Qing Zhou and Wing Wong, personal
communication). It is possible that NF-Y contributes to the
regulation of the peculiar cell cycle pattern of ES cells, with a
short G1 phase and insensitivity to the Rb pathway (reviewed
in [76]). NF-Y had previously been shown to regulate cell
proliferation in other experimental paradigms [69,70], but its
role in early embryonic development remains poorly under-
stood. The strong upregulation of subunits of NF-Y in oocytes
[66] and the ICM [67], and the early arrest of NF-YA mutant
embryos [70], indicates that NF-Y plays important roles
during early embryogenesis. It is also worth noting the
dramatic difference in expression of NF-YA isoforms during
ES cell differentiation (Figure 7A). Both NF-YA isoforms
contain a glutamine-rich region that is reduced in the short
isoform of NF-YA [68]. The glutamine-rich region of NF-YA
has been shown to activate transcription [68,77,78] and it is
also a protein–protein interaction domain [79]. The func-
tional signiﬁcance of the two NF-YA isoforms remains to be
elucidated, although recent data indicate that NF-YA(short)
promotes self-renewal of hematopoietic stem cells [80].
Future studies will address the speciﬁc contribution of NF-
Y and its different subunits, in particular NF-YA(short), in ES
cells.
ES cells may be governed at the molecular level by the
action of cell-speciﬁc transcription factors, such as Oct4 and
Nanog, and factors that are also expressed in other cell types,
such as NF-Y, c-Myc [50], and Stat3 [11]. Interestingly, NF-Y
binds to the promoter of Sall4 (Figure 6C), an essential ES cell
regulator [24]. It will be important to identify the target genes
that are regulated by NF-Y in ES cells. We expect that the
combination of ChIP-chip and expression proﬁling will
reveal the contribution of NF-Y to the transcriptional
program of ES cells.
In summary, we report here the identiﬁcation of clusters of
genes upregulated in pluripotent cells, the development of a
novel algorithm for discovery of short cis-acting regulatory
motifs, the validation of the activity of several novel motifs in
mouse and human pluripotent stem cells, and the identi-
ﬁcation of transcription factor NF-Y as a regulator of gene
expression in ES cells that is required for their proliferation.
Genetic and biochemical approaches should allow the
identiﬁcation of other transcription factors that bind to the
motifs. Our results provide a basis for understanding the
transcriptional regulatory networks that underlie early
mammalian embryogenesis and ES cell self-renewal and
pluripotency.
Materials and Methods
Microarray data analysis. The isolation of PGCs and SGM cells
from 11.5 dpc Oct4/GFP transgenic mouse embryos and the
identiﬁcation of their transcription proﬁles is described elsewhere
(Wei et al, submitted). Brieﬂy, we used 20,000–30,000 PGCs or SGM
cells per replicate sample, and analyzed 3–4 replicates per tissue using
Affymetrix U74Av2 arrays (http://www.affymetrix.com), which assay
for the expression of about 12,000 genes. We normalized, modeled,
and clustered gene expression proﬁles (Dataset S1) using the dChip
software (http://biosun1.harvard.edu/complab/dchip/) [81]. We com-
pared the gene expression proﬁles of PGCs and SGM cells with those
of embryonic and adult stem cells that we had previously described
[42]. Hierarchical clustering was used to identify clusters of genes
associated with pluripotency. A total of 230 probe sets were selected
and used for Gene Ontology term analyses with the Onto-Express
software (http://vortex.cs.wayne.edu/) [43]. p-Values for signiﬁcance of
overrepresentation of functional annotations were calculated in
Onto-Express using a hypergeometric distribution and corrected for
multiple testing using false discovery rate. For motif discovery, a
cluster of 55 probe sets (included in the 230 probe sets used for Gene
Ontology term analyses) was selected by the additional criteria:
downregulation in differentiation of ES cells towards EBs (H.
Chipperﬁeld, S. Zhong, D. Melton, and W. Wong, personal commu-
nication); standard deviation/mean . 0.6. These 55 probe sets are
listed in Dataset S7. Detailed protocols are available upon request.
Computational methods. To identify putative motifs shared among
the pluripotency-associated gene cluster, Affymetrix probe sets were
mapped to Ensembl (http://www.ensembl.org) gene annotation v.27
(Dataset S17) [82,83]. Both 1,000 bp and 2,000 bp of the intergenic
sequences upstream from the transcriptional start site were extracted
for each gene. For each of the different lengths, three sets of
sequences were extracted from Ensembl; the ﬁrst set contained the
sequences of all annotated genes in the cluster in mouse (build 33),
the second set contained the sequences from the orthologous human
(build 35) genes in the cluster obtained from Ensembl mapping
[83,84], and the last set consisted only of concatenated blocks of
mouse promoter sequences that were conserved between mouse and
human within the speciﬁed upstream sequence length. Pairwise
alignments between mouse (mm5) and human (hg17) were obtained
from the University of California Santa Cruz Genome Browser
database (http://genome.ucsc.edu) [85–87].
Next, the three sets of upstream sequences were repeat masked
(http://www.repeatmasker.org) and then used as input for the
MobyDick algorithm [28,88] to build three dictionaries of putative
motifs. The adjustable parameters used were as described [57], except
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grouped into one ﬁnal dictionary of motif clusters using the CAST
clustering algorithm [89]. All pairs of motifs in the dictionaries were
scored based on a gapless pairwise alignment using a simple mutation
model [57], after which CAST was applied with the threshold
parameter set at 0.55 (the lower bound of the normalized score
averaged over all pairs in a cluster).
Following the clustering step, we calculated a p-value to identify
motif clusters that were signiﬁcantly overrepresented in the
pluripotency-associated gene cluster compared to a background
contrast set. As our contrast set, we used about 8,500 mouse promoter
regions from the genes on the Affymetrix U74Av2 platform not in the
pluripotency-associated gene cluster. To calculate the p-values, we
counted the number of occurrences of each motif cluster in the
contrast set and calculated the expected number of occurrences
based on a random distribution throughout the genes, Nexp. We then
counted the number of occurrences of each motif cluster within the
mouse promoter regions of the pluripotency-associated gene cluster,
Nobs. Poisson distribution was then used to calculate the probability p
of observing the number of occurrences equal to or greater than Nobs
by chance given the expected number of occurrences Nexp. These p-
values were Bonferroni corrected by the number of clusters.
Ten motif clusters (Table S1) were selected for further exper-
imental characterization based on the following criteria:  log10 p-
values greater than zero after correction for multiple testing,
evolutionary conservation across different promoter dictionaries,
copy number less than 50, and nonrepetitive elements. From our list
of ten motif clusters, we identiﬁed highly conserved motifs by
searching for all occurrences of each motif within the mouse
sequence of the alignment between human, mouse, rat, and dog
[44] and extended the motif to the ﬂanking regions if the ﬂanking
regions were also highly conserved (Dataset S16). A highly conserved
position was deﬁned to be a nucleotide base that was conserved
across all four species.
Construction of reporter vectors. The 242-bp fragment of Oct4 DE
( 2,181 to 1,939) was PCR ampliﬁed from GOF18DPE/EGFP plasmid
[90] using primers Oct4_2 and Oct4_3 (Dataset S18) containing
BglII and BamHI restriction sites. The PCR product was digested and
cloned into the BglII/BamHI digested plasmid pFoXLucTK [91]. Nng
and motif-containing plasmids were cloned by hybridizing comple-
mentary oligos (Dataset S18) that yielded BglII and BamHI restriction
site overhangs and ligating them to BglII/BamHI-digested plasmid
pFoXTKLuc. Upstream genomic sequences of Eed were PCR
ampliﬁed from the mouse genome with primers Eed2 and Eed4
(Dataset S18) and cloned into the pCRII-TOPO vector (Invitrogen,
http://www.invitrogen.com), from which it was subsequently excised
by SpeI/XbaI restriction digest and ligated to SpeI/XbaI digested
pFoxLuc vector [91]. All plasmids were veriﬁed by sequencing.
Cell culture and differentiation. Mouse E14 ES and EG cells were
maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Invi-
trogen) supplemented with 10% fetal bovine serum, 1mM L-
glutamine, 0.1 mM nonessential amino acids, 100u/mL penicillin,
100 lg/ml streptomycin, 1 mM sodium pyruvate, 0.1 mM 2-
mercaptoethanol, and recombinant LIF. Mouse Oct4/GFP ES cells
[73] were grown in identical conditions except that knockout serum
replacement (Invitrogen) was used instead of fetal bovine serum.
Human ES H9 cells were cultured in Knockout DMEM supplemented
with 20% knockout serum replacement (Invitrogen), 1mM L-
glutamine, 0.1 mM nonessential amino acids, 0.1 mM 2-mercaptoe-
thanol, and 10 ng/ml recombinant human FGF-2 on X-ray inactivated
mouse embryonic ﬁbroblasts. Embryoid bodies were formed by
suspension culturing, and chemical differentiation induction was
performed with 0.5 lM all-trans-RA (Sigma, http://www.sigmaaldrich.
com/), both in the absence of LIF. HEK293 and NIH-3T3 cells were
cultured in DMEM containing 10% fetal bovine serum, 1mM L-
glutamine, 100u/ml penicillin, 100 lg/ml streptomycin, and 0.1 mM
nonessential amino acids.
Transfection and luciferase reporter assays. 1.5 3 10
5 cells were
plated in 12-well tissue culture plates 24 h prior to transfection.
Human ES cells were plated on Matrigel (BD Bioscience, http://
www.bdbiosciences.com/), in the absence of mouse feeder cells. Each
reporter construct (500 ng) was cotransfected with the pRL-TK vector
(200 ng) (Promega http://www.promega.com/) as an internal control
using 2 ll of Lipofectamine2000 (Invitrogen), according to manu-
facturer’s instructions. Cells were lysed 24 h after transfection, and
luciferase activities were measured using a dual-luciferase assay
system (Promega).
Electrophoretic mobility-shift assay. Biotin-labeled double-
stranded oligos containing motif 6a and 6b sequences (Figure 4A)
were incubated with 10 lg mouse ES cell nuclear extracts using the
LightShift Chemiluminescent EMSA Kit (Pierce, http://www.piercenet.
com/). The formation of DNA–protein complexes was analyzed by 5%
nondenaturing polyacrylamide gel electrophoresis, followed by semi-
dry transfer to the GeneScreen membrane (PerkinElmer, http://www.
perkinelmer.com/) and biotin detection using the LightShift Kit
according to manufacturer’s instructions. For supershift assays, 2 lg
or 6 lgo fa-NF-YA (ab6558; Abcam, http://www.abcam.com/) or a-NF-
YB (ab6559, Abcam) were added.
ChIP. ChIP was performed essentially as described in [23] and by
Upstate Biotechnology (http://www.upstate.com). Brieﬂy, chromatin
was cross-linked using 1% formaldehyde for 10 min, the reaction was
quenched with 1/20 volume of 2.5 M glycine and centrifuged at 1,350
3g for 5 min, and the pellet was washed with PBS and sonicated to
obtain fragments of ;100–600 bp, as veriﬁed on a gel. Reactions were
centrifuged at 20,000 3g for 10 min and the supernatants were used
for incubations with a-NF-YB (FL207; Santa Cruz Biotechnology,
http://www.scbt.com/) or a-V5 (ab9137, Abcam) overnight at 4 8C.
Dynal Protein G beads (Invitrogen) were used for magnetic recovery
of antibody-bound chromatin following the manufacturer’s instruc-
tions. Crosslinking was reversed by incubation at 65 8C overnight.
Reactions were digested with RNAse A and Proteinase K and DNA
was puriﬁed by phenol–chloroform extraction and ethanol precip-
itation. DNA concentration was determined using a Nanodrop
(NanoDrop Technologies, http://www.nanodrop.com/) and 8 ng were
used in Sybr Green real-time PCRs (see below) ran in duplicates or
triplicates. Primer sequences are available upon request. Fold
enrichment was calculated using the 2
DCt method. The gene Rpl15
was used as control. All PCRs were veriﬁed on a gel for the presence
of a single band of the correct size.
RNAi and competition assay. shRNA sequences were selected
according to published criteria [92]: GFPi-ACAGCCACAACGTCTA-
TAT, Oct4i-GAACCTGGCTAAGCTTCCA, NF-YBi1-GTAGTTC-
TAGCTCTATCAA, NF-YBi2-GACTAATTGAGGTGTTAAT, NF-
YAi1-GAGACAGTTTAGAGAGTAA, NF-YAi2- GAAGTGTTGAGGA-
CATTCA, and control-ACAGCCACAACGTCTATAT. Oligos coding
for the shRNAs were designed and cloned into the lentiviral vector
pSicoR-mCherry as described [93]. pSicoR-mCherry was generated by
replacing mCherry for GFP in pSicoR.
Lentiviruses were produced as described [93]. For transduction,
10
6 ES cells were incubated with virus in 1 ml of ES cell medium
(multiplicity of infection 5–10). After 1 h rotating at 37 8C, 2.5310
5–3
3 10
5 cells were plated per gelatinized well of a 12-well plate. Cells
were passaged and a sample collected for analysis every 2 d. The
percentage of mCherryþ cells was determined and mCherryþ and
mCherry cells were isolated using a FACSDiVa (BD Biosciences) cell
sorter.
Real-time RT-PCR. RNA was isolated and reverse transcribed
using the iScript ﬁrst strand cDNA synthesis kit (Bio-Rad Laborato-
ries, http://www.bio-rad.com/). The cDNA reaction was diluted 1:5 in
TE and used in Sybr Green real-time PCRs (Bio-Rad Laboratories).
PCR primers were designed to amplify 100–200-bp fragments
spanning two exons at the 39 end of the gene. Housekeeping genes
used were Ppia (for mouse), Ubb, and ribosomal protein L7 (for mouse
and human), which were determined from the microarray data to not
be differentially expressed in the samples analyzed. PCR primer
sequences are available upon request. Reactions were run in
replicates on a MyiQ qPCR machine (Bio-Rad Laboratories) accord-
ing to the manufacturer’s instructions. Only samples with single and
matching end-point melting curve peaks were used for subsequent
analysis. Cycle threshold values were imported into the REST
software [94] for fold-change calculations, using the housekeeping
genes as controls.
Colony formation assay. Cells were infected with lentiviruses
containing shRNAs and mCherry, as described above. mCherryþ and
mCherry cells were isolated using a FACSDiVa (BD Biosciences) cell
sorter. Three hundred cells were plated per well of a 6-well plate in
triplicates. After 10 d in culture, cells were stained for alkaline
phosphatase using a Vector kit (http://www.vectorlabs.com/) and
colonies were counted.
Cell cycle analysis. Cells were infected with lentiviruses leading to
theexpression of shRNAsandmCherry, asdescribedabove.mCherryþ
and mCherry cells were isolated using a FACSDiVa (BD Biosciences)
cell sorter. Cells were washed twice with cold PBS, resuspended at
concentration of 2 3 10
6 cells/ml in PBS and ﬁxed with cold ethanol.
After overnight incubation at 4 8C, cells were washed twice and
resuspended in 160 ll PBS containing 1% BSA. Twenty microliters of
propidium iodide (0.5 mg/ml) and 20 ll of RNase A (10 mg/ml) were
added, cells were incubated at 37 8C for 30 min, and analysis was
performed using a FACScalibur ﬂow cytometer and FloJo.
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Dataset S11. CompMoby Results for 2-kb Mouse Dictionary
Found at doi:10.1371/journal.pgen.0030145.sd011 (47 KB XLS).
Dataset S12. CompMoby Results for 2-kb Human Dictionary
Found at doi:10.1371/journal.pgen.0030145.sd012 (42 KB XLS).
Dataset S13. CompMoby Results for 2-kb Conserved Blocks Dic-
tionary
Found at doi:10.1371/journal.pgen.0030145.sd013 (46 KB XLS).
Dataset S14. CompMoby Results for 1-kb Final Dictionary Where All
1-kb Dictionaries Are Clustered by Sequence Similarity
Found at doi:10.1371/journal.pgen.0030145.sd014 (59 KB XLS).
Dataset S15. CompMoby Results for 2-kb Final Dictionary Where All
2-kb Dictionaries Are Clustered by Sequence Similarity
Found at doi:10.1371/journal.pgen.0030145.sd015 (40 KB XLS).
Dataset S16. Conservation of Motif Clusters across Four Species
Alignment of Human, Mouse, Rat, and Dog
Found at doi:10.1371/journal.pgen.0030145.sd016 (27 KB XLS).
Dataset S17. Ensembl Probes Used for CompMoby Analysis
Found at doi:10.1371/journal.pgen.0030145.sd017 (14 KB XLS).
Dataset S18. Oligos Used for Motifs
Found at doi:10.1371/journal.pgen.0030145.sd018 (22 KB XLS).
Figure S1. Increase in the Number of Motif Repeats Leads to a
Proportional Increase in Motif Activity
Predicted motif sequences 1b, 2c and 8a were fused to a construct
containing Fireﬂy luciferase driven by a minimal TK promoter. The
number of repeats for a given motif is indicated below corresponding
bar graph. Constructs 2c and 8a bear one or two repeats of genomic
sequence that each contain two identical predicted regulatory motifs.
The constructs were transfected in undifferentiated mouse ES cells. A
plasmid containing Renilla luciferase driven by the TK promoter was
cotransfected. After 24 h, cells were lysed and assayed for luciferase
activities. Fireﬂy values were corrected for Renilla values, and the
activities of the tested constructs were calculated relative to the
activity of the TK construct, which was set to 1. Representative results
from two to ﬁve independent experiments are shown. Bars represent
averages of triplicates performed in each single experiment. Error
bars depict standard deviation.
Found at doi:10.1371/journal.pgen.0030145.sg001 (220 KB PDF).
Table S1. Position of Motifs from Transcriptional Start Sites
Found at doi:10.1371/journal.pgen.0030145.st001 (40 KB XLS).
Accession Numbers
The gene expression proﬁles of ES cells, PGCs, and somatic cells can
be obtained from ArrayExpress (http://www.ebi.ac.uk/arrayexpress/),
accession number E-MEXP-1158.
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